Fingerprint
Dive into the research topics where Immunisation & Vaccine Preventable Diseases is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
Research output
-
Assessing the potential impact of the 20-valent (PCV20) and an adult 21-valent (aPCV21) pneumococcal conjugate vaccine on invasive pneumococcal disease in England
Nikhab, A., Patel, T., Rooney, G., Wasti, S., Abdullahi, F., D'Aeth, J. C., Eletu, S., Litt, D. & Ladhani, S. N., 7 Mar 2026, In: Vaccine. 75, p. 128246 128246.Research output: Contribution to journal › Article › peer-review
Open Access -
Disparities in uptake of Shingrix® vaccine in immunosuppressed individuals in England: a population-based cohort study
Barry, E. V. H., Suffel, A. M., Walker, J., Andrews, N., Campbell, C. N. J., Goudie, R., de Lusignan, S., Leston, M., Langan, S. M., Stowe, J., Douglas, I. J., Parker, E. P. K. & Mansfield, K. E., 6 Feb 2026, In: Vaccine. 72, 128078.Research output: Contribution to journal › Article › peer-review
Open Access -
Enhancing MMR vaccination surveillance in England: Comparing and contrasting new individual-level and existing aggregate data sources
Pullen, A., Adekola, A., Farnes, K., Butt, S., Hailstone, S. & Campbell, C. N. J., Feb 2026, In: International Journal of Medical Informatics. 206, 106159.Research output: Contribution to journal › Article › peer-review
Open Access
Impacts
-
Influenza vaccine evaluation drives policy
Watson, C. (Participant), Lopez Bernal, J. (Participant) & Singanayagam, A. (Participant)
Impact: Health impacts, Public policy impacts
File